MedPath

Phase I/II clinical trial of hypofractionated image-guided proton therapy for prostate cancer

Not Applicable
Conditions
localized prostate cancer
Registration Number
JPRN-UMIN000038279
Lead Sponsor
agoya City University West Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1)pathological specimen is not available to confirm the diagnosis 2)previous radiotherapy around the lesion 3)surgery for prostate cancer is performed prior to registration 4)active and uncontrolled infection 5)two or more anticoagulants and antiplatelets 6)bowel disease such as ulcerative colitis or postoperative rectal cancer 7)patients who cannot or refuse gold markers and Space OAR 8)serious complication 9)cases in which the doctor is judged inappropriate for medical or other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The ratio of grade 2 or more acute genitourinary toxicity
Secondary Outcome Measures
NameTimeMethod
5-year OS, bRFS, cRFS, bRF, cRF, Grade 2 or more late toxicity, QOL change
© Copyright 2025. All Rights Reserved by MedPath